• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Bringing Gene Therapies for HIV Disease to Resource-Limited Parts of the World.

作者信息

McCune Joseph M, Turner Emily H, Jiang Adam, Doehle Brian P

机构信息

HIV Frontiers, Global Health Innovative Technology Solutions, Bill & Melinda Gates Foundation, Seattle, Washington, USA.

出版信息

Hum Gene Ther. 2021 Jan;32(1-2):21-30. doi: 10.1089/hum.2020.252. Epub 2020 Oct 30.

DOI:10.1089/hum.2020.252
PMID:32998595
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10112459/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d02/10112459/c983326a99d3/hum.2020.252_figure3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d02/10112459/8f44cd929a81/hum.2020.252_figure1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d02/10112459/ba56c5b432b7/hum.2020.252_figure2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d02/10112459/c983326a99d3/hum.2020.252_figure3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d02/10112459/8f44cd929a81/hum.2020.252_figure1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d02/10112459/ba56c5b432b7/hum.2020.252_figure2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d02/10112459/c983326a99d3/hum.2020.252_figure3.jpg

相似文献

1
Bringing Gene Therapies for HIV Disease to Resource-Limited Parts of the World.将针对艾滋病的基因疗法推广至世界资源匮乏地区。
Hum Gene Ther. 2021 Jan;32(1-2):21-30. doi: 10.1089/hum.2020.252. Epub 2020 Oct 30.
2
Affordable HIV and sickle cell disease gene therapies.可负担得起的艾滋病病毒和镰状细胞病基因疗法。
Nat Rev Drug Discov. 2019 Nov;18(12):895. doi: 10.1038/d41573-019-00189-3.
3
Genetic therapies for HIV infections: promise for the future.用于治疗HIV感染的基因疗法：未来的希望。
AIDS. 1995 Sep;9(9):985-93. doi: 10.1097/00002030-199509000-00002.
4
[This is how the "gene scissors" function against HIV].
MMW Fortschr Med. 2016 Jun 9;158 Suppl 1:10. doi: 10.1007/s15006-016-8315-9.
5
Gene therapy for HIV-1 infection.
Adv Exp Med Biol. 1996;394:421-8. doi: 10.1007/978-1-4757-9209-6_39.
6
Prospects for the therapeutic application of lentivirus-based gene therapy to HIV-1 infection.
Curr Gene Ther. 2008 Feb;8(1):1-8. doi: 10.2174/156652308783688536.
7
An approach to HIV gene therapy by transduction of multifunctional retroviral vectors in primary human T lymphocytes.
J Biol Regul Homeost Agents. 1997 Jan-Jun;11(1-2):79-81.
8
HIV infection and gene transfer therapy.
Hum Gene Ther. 1991 Summer;2(2):111-2. doi: 10.1089/hum.1991.2.2-111.
9
Development of ribozyme gene therapy for HIV infection.
Antibiot Chemother (1971). 1996;48:226-32. doi: 10.1159/000425181.
10
[Retrovirus Restriction Factor TRIM5α: The Mechanism of Action and Prospects for Use in Gene Therapy of HIV Infection].
Mol Biol (Mosk). 2020 Sep-Oct;54(5):707-717. doi: 10.31857/S0026898420050031.

引用本文的文献

1
Progress Note 2024: Curing HIV; Not in My Lifetime or Just Around the Corner?2024年病程记录：治愈艾滋病病毒；是我有生之年无法实现还是指日可待？
Pathog Immun. 2024 Mar 1;8(2):115-157. doi: 10.20411/pai.v8i2.665. eCollection 2023.
2
The promise of a "cure" for HIV: implications for the future of PEPFAR-supported HIV programmes.治愈”艾滋病的前景：对总统艾滋病紧急救援计划（PEPFAR）支持的艾滋病项目未来的影响。
J Int AIDS Soc. 2024 Jan;27(1):e26206. doi: 10.1002/jia2.26206.
3
The long-term impact and value of curative therapy for HIV: a modelling analysis.

本文引用的文献

1
Advances in gene therapy for hematologic disease and considerations for transfusion medicine.血液疾病的基因治疗进展及输血医学相关考虑。
Semin Hematol. 2020 Apr;57(2):83-91. doi: 10.1053/j.seminhematol.2020.07.004. Epub 2020 Jul 28.
2
Distinct viral reservoirs in individuals with spontaneous control of HIV-1.个体中 HIV-1 自发性控制的独特病毒储库。
Nature. 2020 Sep;585(7824):261-267. doi: 10.1038/s41586-020-2651-8. Epub 2020 Aug 26.
3
Recent Advances in the Treatment of Sickle Cell Disease.镰状细胞病治疗的最新进展
长效治疗对 HIV 的长期影响和价值：建模分析。
J Int AIDS Soc. 2023 Sep;26(9):e26170. doi: 10.1002/jia2.26170.
4
Ethical and practical considerations for cell and gene therapy toward an HIV cure: findings from a qualitative in-depth interview study in the United States.细胞和基因治疗实现 HIV 治愈的伦理与实践考量：来自美国深入定性访谈研究的发现。
BMC Med Ethics. 2022 Apr 9;23(1):39. doi: 10.1186/s12910-022-00780-1.
5
Collaborative science to advance gene therapies in resource-limited parts of the world.开展合作科研，推动在世界资源匮乏地区的基因治疗。
Mol Ther. 2021 Nov 3;29(11):3101-3102. doi: 10.1016/j.ymthe.2021.05.024. Epub 2021 Aug 30.
Front Physiol. 2020 May 20;11:435. doi: 10.3389/fphys.2020.00435. eCollection 2020.
4
TIGIT Blockade: A Multipronged Approach to Target the HIV Reservoir.TIGIT阻断：一种针对HIV储存库的多管齐下方法。
Front Cell Infect Microbiol. 2020 May 5;10:175. doi: 10.3389/fcimb.2020.00175. eCollection 2020.
5
The Biology of the HIV-1 Latent Reservoir and Implications for Cure Strategies.HIV-1 潜伏库的生物学特性及其对治愈策略的影响。
Cell Host Microbe. 2020 Apr 8;27(4):519-530. doi: 10.1016/j.chom.2020.03.014.
6
Long-Term Delivery of an Anti-SIV Monoclonal Antibody With AAV.AAV 长效递送抗 SIV 单克隆抗体。
Front Immunol. 2020 Mar 17;11:449. doi: 10.3389/fimmu.2020.00449. eCollection 2020.
7
CD8 T cells in HIV control, cure and prevention.HIV 控制、治疗和预防中的 CD8 T 细胞。
Nat Rev Immunol. 2020 Aug;20(8):471-482. doi: 10.1038/s41577-020-0274-9. Epub 2020 Feb 12.
8
Permanent control of HIV-1 pathogenesis in exceptional elite controllers: a model of spontaneous cure.HIV-1 持续控制的精英控制者：自发性治愈的模型。
Sci Rep. 2020 Feb 5;10(1):1902. doi: 10.1038/s41598-020-58696-y.
9
Combination anti-HIV-1 antibody therapy is associated with increased virus-specific T cell immunity.联合抗 HIV-1 抗体治疗与增加病毒特异性 T 细胞免疫有关。
Nat Med. 2020 Feb;26(2):222-227. doi: 10.1038/s41591-019-0747-1. Epub 2020 Feb 3.
10
Combination Immune Checkpoint Blockade to Reverse HIV Latency.联合免疫检查点阻断逆转 HIV 潜伏期。
J Immunol. 2020 Mar 1;204(5):1242-1254. doi: 10.4049/jimmunol.1901191. Epub 2020 Jan 27.